WELL Health Technologies Corp.

TSX:WELL.TO

Medical - Care Facilities

Healthcare
$3.70 +0.34%

+$0.02 today

Market cap
$947.00M
Beta
1.33
P/E (TTM)
41.6
EPS (TTM)
$0.11
52W Low $3.58High $6.08

Volume 2.80M

Average 1.62M

WELL.TO EBITDA

Earnings before interest, taxes, depreciation, and amortization; a proxy for operating profit before non-cash and financing charges.

WELL Health Technologies Corp.TSX: WELL.TO

EBITDA · Q1 FY2026 · quarter ended Mar 2026

EBITDA turns positive

Q1 FY2026 EBITDA was CA$45.34M, compared with -CA$12.63M a year earlier. Trailing-twelve-month EBITDA was CA$219.35M. Over 3 fiscal years it compounded at +29.6% a year.

Context

  • EBITDA amounted to 14.8% of revenue in FY2025, up 1.4 pp from a year earlier.
  • EBITDA increased in 3 of the last 3 fiscal years.
  • FY2025 was the highest annual figure in the 4 fiscal years shown.

What to watch

Whether EBITDA reaches the consensus estimate from 14 analysts of CA$926.03M (+347.8%) for the fiscal year ending Dec 2026, a step up from the +68.8% reported in FY2025.

Sources:Income Statement Analyst consensus estimates Text generated from reported figures; not investment advice.

Latest quarterMar 2026
CA$45.34M-26.3% QoQ
Last fiscal yearDec 2025
CA$206.79M+68.8% YoY
LTMMar 2026
CA$219.35M+256.2% YoY
EBITDA past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+459.0%+14.5%-444.5 pp
1 year+68.8%+347.8%+279.0 pp
3-year CAGR+29.6%+94.1%+64.5 pp
5-year CAGR——
10-year CAGR——

Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.

EBITDA history

CAD · from the income statement

Latest · FY2025
206.79M CAD
Year-over-year change
+68.8%
4-year CAGR
+76.6%
Reported Analyst consensus estimate Further estimates hidden. Sign in to unlock

EBITDA vs competitors

How WELL.TO compares with its peers on the latest reported figures

  • Peers report in different currencies, so EBITDA is compared through growth and share of revenue rather than absolute size.
  • Its year-over-year change of +256.2% is the 2nd highest of 5, against a peer median of +34.2%.
  • EBITDA amounts to 14.9% of revenue for WELL.TO, versus a peer median of 21.5%.
WELL.TO Competitors
EBITDA for WELL.TO and competitors
Company Period LTM YoY 3-year CAGR% of revenue
WELL.TOWELL Health Technologies Corp.LTM Mar 2026CA$219.35M CAD+256.2%+29.6%14.9%
EXE.TOExtendicare Inc.LTM Jun 2026CA$213.41M CAD+28.5%+52.7%10.8%
SIA.TOSienna Senior Living Inc.LTM Sep 2026CA$202.95M CAD+39.8%+16.4%18.3%
DR.TOMedical Facilities CorporationLTM Mar 2026$75.52M USD-3.6%+5.1%24.7%
CRON.TOCronos Group Inc.LTM Mar 2026$47.83M USD+356.7%—30.0%
Peer median (excluding WELL.TO) —+34.2%+16.4%21.5%

Competitors are the stored peer set for WELL.TO. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

CAD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue302.32M569.14M776.05M919.69M1.4B
Cost of Revenue148.63M265.85M403.79M556.68M875.1M
Gross Profit153.7M303.29M372.27M363.01M525.08M
Gross Margin50.8%53.3%48.0%39.5%37.5%
Research & Development03.15M3.46M00
Selling, General & Admin123.52M224.11M276.98M321.47M432.38M
Operating Expenses161.74M279.31M337.11M393.21M412.05M
Depreciation & Amortization38.71M55.2M60.77M72.31M93.76M
EBITDA21.27M95.07M101.88M122.52M206.79M
EBITDA Margin7.0%16.7%13.1%13.3%14.8%
Operating Income(6.21M)23.31M35.16M(30.2M)113.03M
Operating Margin-2.1%4.1%4.5%-3.3%8.1%
Interest Income555K649K763K1.27M1.72M
Interest Expense7.84M22.86M32.32M36.88M54.47M
Other Income / Expenses(11.99M)(5.79M)(15.66M)39.19M(107.72M)
Income Before Tax(24.77M)17.92M19.5M8.99M5.31M
Pre-Tax Margin-8.2%3.1%2.5%1.0%0.4%
Income Tax Expense5.92M(1.15M)2.86M(20.1M)846K
Net Income(30.69M)19.07M82K32.61M(50.21M)
Net Margin-10.2%3.4%0.0%3.5%-3.6%
EPS (Basic)(0.16)0.090.000.13(0.03)
EPS (Diluted)(0.16)0.090.000.13(0.03)
Weighted Avg Shares190.9M220.69M236.54M246.76M1.67B
Weighted Avg Shares (Diluted)190.9M220.69M236.54M254.65M1.73B

WELL Health Technologies Corp.

TSX:WELL.TO

Intrinsic Alpha fair value

Locked

Current Price

$3.70

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.